What evidence is there for a delay in diagnostic coding of RA in UK general practice records? An observational study of free text by Ford, E et al.
What evidence is there for a delay in
diagnostic coding of RA in UK general
practice records? An observational study
of free text
Elizabeth Ford,1 John Carroll,2 Helen Smith,1 Kevin Davies,3 Rob Koeling,2
Irene Petersen,4,5 Greta Rait,4 Jackie Cassell1
To cite: Ford E, Carroll J,
Smith H, et al. What evidence
is there for a delay in
diagnostic coding of RA in
UK general practice records?
An observational study of free
text. BMJ Open 2016;6:
e010393. doi:10.1136/
bmjopen-2015-010393
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-010393).
Received 3 November 2015
Revised 26 February 2016
Accepted 7 March 2016
1Division of Primary Care and
Public Health, Brighton and
Sussex Medical School,
Falmer, Brighton, UK
2Department of Informatics,
University of Sussex, Falmer,
Brighton, UK
3Division of Medicine,
Brighton and Sussex Medical
School, Falmer, Brighton, UK
4Research Department of
Primary Care and Population
Health, UCL, London, UK
5Department of Clinical
Epidemiology, Aarhus
University, Denmark
Correspondence to
Dr Elizabeth Ford;
e.m.ford@bsms.ac.uk
ABSTRACT
Objectives: Much research with electronic health
records (EHRs) uses coded or structured data only;
important information captured in the free text
remains unused. One dimension of EHR data quality
assessment is ‘currency’ or timeliness, that is, data
are representative of the patient state at the time of
measurement. We explored the use of free text in
UK general practice patient records to evaluate
delays in recording of rheumatoid arthritis (RA)
diagnosis. We also aimed to locate and quantify
disease and diagnostic information recorded only in
text.
Setting: UK general practice patient records from
the Clinical Practice Research Datalink.
Participants: 294 individuals with incident
diagnosis of RA between 2005 and
2008; 204 women and 85 men, median age
63 years.
Primary and secondary outcome measures:
Assessment of (1) quantity and timing of text entries
for disease-modifying antirheumatic drugs (DMARDs)
as a proxy for the RA disease code, and (2) quantity,
location and timing of free text information relating to
RA onset and diagnosis.
Results: Inflammatory markers, pain and DMARDs
were the most common categories of disease
information in text prior to RA diagnostic code;
10–37% of patients had such information only in text.
Read codes associated with RA-related text included
correspondence, general consultation and arthritis
codes. 64 patients (22%) had DMARD text entries
>14 days prior to RA code; these patients had more
and earlier referrals to rheumatology, tests, swelling,
pain and DMARD prescriptions, suggestive of an
earlier implicit diagnosis than was recorded by the
diagnostic code.
Conclusions: RA-related symptoms, tests, referrals
and prescriptions were recorded in free text with 22%
of patients showing strong evidence of delay in
coding of diagnosis. Researchers using EHRs may
need to mitigate for delayed codes by incorporating
text into their case-ascertainment strategies. Natural
language processing techniques have the capability to
do this at scale.
INTRODUCTION
Electronic health records (EHRs) are in-
creasingly used for epidemiological research,
clinical audit and service evaluation in
chronic conditions, such as rheumatoid arth-
ritis (RA).1–4 For example, UK general prac-
tice patient records from the Clinical
Practice Research Datalink (CPRD) have
been used to audit treatment of RA in the
population,5–7 to evaluate the accuracy of
rheumatoid factor test8 and to assess the risks
to patients while using disease-modifying
antirheumatic drugs (DMARDs) and bio-
logical therapeutic agents.9 10
General practice EHRs
In the UK, 98% of the population is regis-
tered with a general practitioner (GP), and
GP operates as the gatekeeper to all second-
ary care health services. GPs record all facets
of care the patient receives in electronic
patient records, including correspondence to
and from hospital specialists. GPs record
using a medical coding system called Read
codes,11 12 a hierarchical system covering
diagnoses, symptoms, tests, referrals,
Strengths and limitations of this study
▪ A study using general practice patient records
from Clinical Practice Research Datalink, repre-
sentative of the UK population.
▪ 218 000 words of medical free text were anno-
tated in triplicate by domain experts, with adjudi-
cation by a senior clinician.
▪ We did not mark negation or modifiers within
the text, so it is unknown what influence these
linguistic features would have on our under-
standing of the results.
▪ Data were collected between 2005 and 2008 and
it is not clear how changes to clinical practice in
the last decade may have influenced recording.
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administrative codes and correspondence, as well as free
text notes. GPs record prescriptions using British
National Formulary or product codes.
Data quality in general practice patient records
Data quality in EHR data is thought to comprise several
dimensions such as completeness, correctness, concord-
ance, plausibility and currency or timeliness.13 14 Data
are considered current or timely if they are recorded in
the EHR within a reasonable period of time following
measurement and they are representative of the patient
state at the time of measurement. Currency has been
assessed the least in validation studies of EHR data.13
The majority of studies using general practice patient
record data use only coded information. If diagnostic
coding is delayed, research using general practice patient
records using only codes may miss cases, as codes are not
‘representative of the patient state at the time of measure-
ment’.15 The issues of delayed diagnostic codes may pri-
marily affect conditions where diagnoses are made in
secondary care, such as RA, as the transfer of information
can lead to slippage in primary care coding.
The validity of inﬂammatory arthritis codes in UK
general practice electronic patient records is thought to
be good; that is, if there is an arthritis code, it is highly
likely that the patient has the disease.16 However, no val-
idation studies of RA in UK general practice records
have assessed the sensitivity of RA codes, or their timeli-
ness in application.
GPs’ use of text in patient records
The way that GPs use Read codes varies, but many
describe choosing a ‘summary’ code which is a keyword
representing the main body of the consultation.17 The
GP may then add text under the code to capture com-
plexity, evolving circumstances, uncertainty and severity.18
Some examples of codes and the accompanying free text
are shown verbatim in table 1. Letters received from spe-
cialists can also be added to the record as free text.
The use of free text to identify delays in coding
Previous studies using CPRD data to investigate delays in
diagnosis of ovarian cancer in UK general practice
found that 45% had text indicating a deﬁnite diagnosis
of cancer, and in 22% this was before the coded
date.19 20 No such investigation has previously been con-
ducted in RA, but there is evidence from US-based EHR
studies that free text can make RA case ascertainment
more sensitive. A study using US hospital records to ﬁnd
cases of RA found that a single International
Classiﬁcation of Diseases, ninth revision (ICD-9) disease
code for RA had a positive predictive value (PPV) of
only 19%, a combination of coded data achieved a PPV
of 56% and an algorithm incorporating text attained a
PPV of 94%.21 The addition of text to the algorithm
increased the sample size by 26%.21
Why should we investigate delay in coding RA?
RA affects between 0.5% and 1% of the population,22 23
and is characterised by joint swelling, joint tenderness
and destruction of synovial joints, leading to severe dis-
ability.24 RA is an autoimmune condition, and it is recog-
nised that its early active management with treatment by
DMARDs and biologic therapies can slow progression to
disability.25 26 The UK National Institute for Health and
Care Excellence (NICE) issued guidance in 2009 for the
treatment of RA, recommending early intervention with
DMARD combination therapy,27 and CPRD studies have
been used to evaluate the population-wide adherence to
these guidelines.5–7 The care pathway for patients with
RA in the UK varies by region, but frequently there is a
referral from general practice, diagnosis and manage-
ment recommendations by hospital specialists, which are
then communicated back to general practice for
ongoing management.28 In a previous study, we found
that the free text keywords ‘rheumatoid arthritis’ were
most commonly found associated with the Read codes
‘Letter from specialist’, ‘Seen in rheumatology clinic’
and ‘Incoming mail NOS’,17 suggesting that diagnostic
Table 1 Read codes from general practice patient records and examples of accompanying free text
Code Accompanying text
N06z.11 Arthritis Generally worse—quite immobile at times—knees and wrists swollen
N245.14 Hand pain Pain in small joints in both hands—some hurt more than others. Wrists also in
problem. O/E—tender over MCP and PIP joints of the index finger in both
hands. Wrist movement painful. No joint swelling
6A…00 Patient reviewed Increased joint pains, concerned if SE of hydroxychloroquine. Pain in shoulders
and hands on mobilisation—more likely to be Rh A, awaiting appointment at
rheumatology
8C1B.00 Nursing care blood sample taken FBC, ESR, UE, SLFT, fasting glucose, TFT, CHOL, CRP, PSA, urate
1992.00 Vomiting Since waking this morning. No haemoptysis. O/E—looks pale and unwell.
Abdomen soft, bowel normal. Had a motion this morning/normal. Stop
prednisolone and indometacin. Twice omeprazole and take gaviscon (QDS). Do
Hb/ESR/CRP to check progress of arthritis. Symptoms of arthritis completely
disappeared. No history of indigestion
CHOL, cholesterol; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; FBC, full blood count; Hb, haemoglobin; MCP,
metacarpophalangeal; O/E, on examination; PIP, proximal interphalangeal; PSA, prostate specific antigen; Rh A, rheumatoid arthritis; SE, side
effect; SLFT, liver function test; TFT, thyroid function test; UE, urea and electrolytes.
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information contained in letters was not coded at the
time of receipt of the letter. We argue that if RA diagno-
ses are not coded in a timely way, UK general practice
records will lack ‘currency’, and studies such as Edwards
et al5 will not reﬂect accurately the treatment of RA in
the UK.
We thus investigated delay in coding of RA in UK
general practice patient records by analysing the free
text, with two aims:
▸ To quantify RA-relevant information found in free
text, in terms of its quantity, timing and association
with Read codes.
▸ To estimate delayed diagnostic coding of RA, by using
DMARD in text as a proxy for RA diagnosis. These
medications are generally only initiated by rheumatol-
ogists following deﬁnitive diagnosis of RA, after which
prescriptions are continued in primary care, and may
therefore be a good diagnostic marker.
Our hypothesis was that DMARDs mentioned in text
prior to diagnostic code would be a marker for an RA
diagnosis that had not yet been coded.
METHODS
Ethics statement
This research was approved by the UK MHRA Independent
Scientiﬁc Advisory Committee, protocol no. 09_033R.
Study design
This was an observational study of routinely collected
UK general practice data.
Data sources and study population
The CPRD is an electronic database of anonymised lon-
gitudinal patient records from general practice (http://
www.cprd.com). Established in 1987, it is a UK-wide data
set covering 8.5% of the population, with data from over
600 practices. It is broadly representative of the UK
population, with 5.2 million currently active patients.29
Records are derived from the general practice computer
system VISION (In Practice Systems; http://www.inps4.
co.uk/) and contain complete prescribing and coded
diagnostic and clinical information as well as informa-
tion on tests requested, laboratory results and referrals
made. Quality is assured by various assessments, includ-
ing the practice-level ‘up-to-standard’ assessment which
is derived from 10 data quality parameters.
Read codes
Read codes are a hierarchically structured vocabulary
developed by a UK GP, Dr James Read, in the 1980s.
They map to other nomenclatures such as ICD codes
and International Classiﬁcation of Primary Care (ICPC)
codes. Each Read code represents a term or short
phrase describing a health-related concept. There are
over 200 000 different codes, which are sorted into cat-
egories (diagnoses, processes of care and medication)
and subchapters.30 Each clinical entity is represented by
a 5-byte alphanumeric code and a Read term which is
the plain language description.
Identification of cases
From the target population of permanently registered
patients in the study period of 1 January 2005–31
December 2008, 294 cases were identiﬁed at random
who had a ﬁrst diagnostic code of RA within the study
period (code list published elsewhere31), were aged
30 years and over at the time of diagnosis and who had
records available from ‘up-to-standard’ practices, from
1 year before the ﬁrst coded diagnosis of RA to 14 days
afterwards. This sample size was chosen as the maximum
number feasible to obtain given limitations on acquiring
and handling such a large volume of text (218 000
words), and given anonymised free text is only available
from CPRD at considerable additional cost.
Development of indicator code groups
We drew up lists of codes that were indicative of
RA-related activity in the record (indicator code groups)
based on clinical consultation and code list dictionaries.
These were then modiﬁed by reviewing the codes actu-
ally used in the records of patients with RA before the
diagnostic code was found in their records. This process
(published elsewhere; ref. 31) generated eight indicator
code groups of interest for the current study: (1) disease-
modifying antirheumatic drug (DMARD) prescription, (2)
referral to rheumatology specialist, (3) initial inﬂammatory
arthritis diagnosis, (4) rheumatoid factor test, (5) synovitis, (6)
joint signs and symptoms, (7) other arthritis diagnosis and (8)
non-speciﬁc inﬂammatory marker tests.
Free text data
All text strings in the records were accessed, from a
period beginning with the ﬁrst of 1 year before the ﬁrst
RA code, the ﬁrst DMARD prescription or the ﬁrst spe-
ciﬁc marker date (if earlier than 1 year); up to a
maximum of 2 years before the ﬁrst RA code. The
period ended 14 days after the ﬁrst RA diagnostic code.
All text strings were manually anonymised in a three-
stage process at CPRD before being released to the
research team.
Information extraction from text
Information was extracted from text by manual review.
All text strings were triple annotated by senior medical
students following standardised guidelines. Annotators
used an annotation workbench created with the Visual
Tagging Tool software32 which allowed relevant strings to
be highlighted and assigned a category or subcategory.
Disagreements between annotators were adjudicated by
a senior clinician ( JCas).
Categorisation of free text strings
The free text was mapped onto the indicator code
groups (table 2): (1) rheumatoid arthritis; (2) diagnosis or
sign of inﬂammatory arthritis, (3) rheumatoid factor test
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(subcategories: test done, positive result, negative result), (4)
referral to rheumatology, (5) synovitis, (6) DMARD prescrip-
tion; (7) other arthritis symptoms or diagnosis, (8) non-speciﬁc
inﬂammatory marker tests and (9) joint pain or swelling symp-
toms (subcategories: pain, swelling/inﬂammation, movement/
stiffness, effusion).
Statistical analysis
The number and timing of free text strings were tabu-
lated. Non-parametric tests (Kruskal-Wallis) were used
for comparison of median differences as data were
found to be skewed. The ﬁnal data were prepared and
analysed using Stata V.11.2 (StataCorp LP, Texas, USA).
RESULTS
Study population
In total, 6387 newly diagnosed cases of RA were identiﬁed
between 2005 and 2008 comprising 2007 men and 4380
women. Of these cases, a random sample was extracted of
85 men of median age 65 years (IQR 55–75 years) and
209 women of median age 63 years (IQR 50–74 years).
Table 2 Rheumatoid arthritis indicator categories for annotation
Main category Examples
Rheumatoid arthritis ▸ Rheumatoid* (eg, rheumatoid lung, rheumatoid disease)
A diagnosis or sign of inflammatory arthritis ▸ Polyarthritis
▸ Polyarthropathy
▸ Palindromic rheumatism
▸ Rheumatic arthritis
▸ Psoriatic or gouty arthropathy
▸ Arthritis or arthropathy linked to infection
Rheumatoid factor test
1. Test done NOS
2. Positive result
3. Negative result
▸ Latex test
▸ Heterophile
▸ IgA agglutination test
▸ Rose-Waaler test
▸ Rheumatoid factor level
▸ RAHA test
Referral to rheumatology ▸ Rheumatology disorder monitoring
▸ Rheumatology treatment change
▸ Rheumatology management plan given
▸ Under care of rheumatologist
Synovitis –
DMARD prescription ▸ Separate table given for drug names
Other arthritis symptoms or diagnosis ▸ Allergic arthritis
▸ Transient arthropathy
▸ Unspecified polyarthropathy
▸ Unspecified monoarthritis
▸ Other specified arthropathy
▸ Arthritis NOS
Immune/inflammatory markers that are not specific to RA ▸ Antinuclear factor
▸ Antimitochondrial autoantibody
▸ Antismooth muscle autoantibody
▸ Parietal cell autoantibodies
▸ Autoimmune profile
▸ Antiliver kidney microsomal antibody level
▸ Plasma C reactive protein
▸ Serum C reactive protein level
Joint pain or swelling symptoms
1. Pain
2. Swelling/inflammation
3. Movement/stiffness
4. Effusion
▸ Knee pain
▸ Joint abnormal
▸ Joint swelling
▸ Reduced joint movement
▸ Joint movement painful
▸ Joint stiffness
▸ Inflammation in the joint
▸ Movement limitation
▸ Joint pain
▸ Joint effusion
*Indicates a 'wildcard' character where any term beginning with the keyword stem would be accepted for the search.
Arthritis of the MCP is a distinguishing feature of rheumatoid arthritis.
DMARD, disease-modifying antirheumatic drug; IgA, immunoglobulin A; RA, rheumatoid arthritis; MCP joint, metacarpophalangeal joints.
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Relevant free text strings
In total, these 294 patients had 34 738 events recorded
during the study period, of which 11 965 had text asso-
ciated with the events (34.4%). Of these, strings were
marked up with 4340 incidences of information related
to RA in the 15 disease indicator categories prespeciﬁed
(table 2).
Quantity and timing of free text information prior to RA
diagnosis
Table 3 shows the percentages of patients with disease
information in text, codes and the proportion for whom
information was only found in text. It also gives the
median time intervals between the ﬁrst text entry of
each category in the patient record and the index date
of RA diagnostic code (a positive value indicates event
was before RA code). The earliest recorded information,
on average, was rheumatoid (Rh) factor test with a nega-
tive result, other arthritis diagnoses and various joint
signs and symptoms.
Association of text and codes
Table 4 shows the top 20 codes under which RA-relevant
text information was found, representing 56.6% of all
RA-related text information. In total, 24.7% of relevant
text information was found under the top three codes,
‘letter from specialist’, ‘patient reviewed’ and ‘seen in
rheumatology clinic’. The majority of information was
found under communication codes (7 of 20 codes) and
general consultation codes (3 of 20).
DMARD in text as a proxy for RA diagnosis
How many patients have DMARD>14 days prior to their
code?
The earliest date that DMARDs were found in each
patient’s record is shown in ﬁgure 1. Sixty-four patients
(22%) had DMARD text entries earlier than 14 days
before the RA code, and these patients formed the
‘early DMARD group’. Those without an early DMARD
entry formed the ‘comparison group’. Early DMARD
patients had a median of four text entries about
DMARDS (max 68), spanning up to 725 days (2 years)
prior to RA code.
Comparison with early DMARD codes
Fifty-seven patients had codes for DMARD more than
14 days earlier than the RA diagnostic code (19%). The
intervals between earliest DMARD in text and RA code,
and earliest DMARD code and RA code, were highly cor-
related (r=0.63, p<0.001), but the two groups of patients
were not identical; 44 patients had early DMARDs in
text and code (this was 77% of the group with early
codes and 69% of the group with early text).
Evidence of delayed diagnostic recording in patients with
early DMARD
The early DMARD group (N=64) did not differ from
the comparison group in age or gender. They had more
free text entries prior to their diagnostic code, a median
of 20.5 vs 8 (Kruskal-Wallis test, p<0.001). In particular,
they had more text entries prior to RA code referring to
DMARDs, inﬂammatory arthritis, other arthritis, referrals
Table 3 Number and timing of free text string events compared with timing of coded information
Category
Patients with text
entry (N) (%)
Patients with
equivalent code (N) (%)
Patients with
text only (N) (%)
Median time earliest text entry
prior to RA code (days) (IQR)
DMARD 114 (39%) 131 (45%) 27 (9%) 38 (0–281)
Rheumatoid arthritis 121 (41%) 294 (100%) – 34 (0–168)
Inflammatory arthritis 63 (21%) 33 (11%) 53 (18%) 140 (28–256)
Other arthritis 124 (42%) 41 (14%) 109 (37%) 148 (37.5–361)
Synovitis 54 (18%) 11 (4%) 48 (16%) 82 (16–206)
Referral to
rheumatology
126 (43%) 122 (42%) 61 (21%) 68.5 (14–181)
Joint pain 193 (66%) – – 169 (52–356)
Effusion 28 (10%) – – 102 (15.5–278)
Stiffness 108 (37%) – – 116.5 (18.5–263)
Swelling 137 (47%) – – 148 (35–302)
Any joint symptom 221 (75%) 133 (45%) 106 (36%)
Rh test, no result 94 (32%) – – 47.5 (17–154)
Positive Rh test 62 (21%) – – 66 (8–169)
Negative Rh test 25 (8.5%) – – 178 (11–334)
Any Rh test reference 135 (46%) 163 (55%) 26 (9%)
Steroids 86 (29%) – – 119 (18–372)
Non-specific
inflammatory
markers
185 (63%) 181 (62%) 52 (18%) 120 (23–298)
DMARD, disease-modifying antirheumatic drug; RA, rheumatoid arthritis; Rh, rheumatoid factor.
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to rheumatology and the symptom of swelling, than the
comparison group (all p<0.002).
Text entries for disease indicators also occurred much
earlier in the early DMARD group: inﬂammatory arthritis
was mentioned ﬁrst at a median of 192 days in the early
DMARD group versus 78 days in the comparison group
(p=0.03); for other arthritis diagnoses this difference was
281 vs 77 days (p=0.0001); for referral to rheumatology
the difference was 218 vs 33 days (p=0.0001) and for swel-
ling it was 245 vs 85 days (p=0.0001). RA was found in
text at a median of 214.5 days prior to RA code in the
early DMARD group compared with 14 days prior to RA
code in the comparison group (p=0.0001); a positive Rh
factor test was mentioned in text at a median of
186.5 days prior to RA code in the record vs 31 days for
comparison group (p=0.007); and pain was also men-
tioned early, at a median of 251.5 vs 138 days (p=0.002).
Differences were not found in the number of codes that
patients had, except that the early DMARD group had
more DMARD prescriptions in their record. They had
no greater number of codes for inﬂammatory arthritis
or other arthritis diagnoses than the comparison group
(p>0.05), although codes for these were reported earlier
in the early DMARD group (inﬂammatory 147 vs
63.5 days, p=0.05; other arthritis 157.5 vs 56, p=0.048).
Codes for referral to rheumatology (245 vs 16 days,
p=0.0001) and Rh factor test (180 vs 35 days, p=0.0001)
were found earlier in the early DMARD group.
DISCUSSION
We investigated the utility of free text for evaluating the
EHR data quality dimension of ‘currency’. The results of
our study suggest that free text information relevant to
RA diagnosis was widespread and was found under cor-
respondence codes, general consultation codes and
general symptom codes. When information from text
was added to the information in codes, 10–37% more
patients were found to have evidence of each of the RA
disease indicators that we investigated.
We showed good evidence for a group of patients who
were likely to have a working diagnosis of RA, and were
being treated with DMARDs, up to 2 years before the
RA diagnosis was coded in primary care. These patients
had signiﬁcantly more information in text suggesting
they had been through a formal diagnostic process (eg,
referral to rheumatology, tests and RA keywords). These
ﬁndings have implications for EHR research and for the
delivery and planning of clinical care.
Implications for EHR research
Very little previous work has sought to use information
from text to establish delayed recording of diagnosis in
EHR research. Tate et al19 20 looked at free text for con-
ﬁrmation of a diagnosis of ovarian cancer, and showed
that 22% of patients had text suggesting a diagnosis
before the ovarian cancer code, a similar proportion to
Table 4 Top 20 codes for all relevant text entries
(total=4340)
Code Frequency
% of all
strings
Letter from specialist 486 11.20
Patient reviewed 296 6.82
Seen in rheumatology clinic 290 6.69
Pain in joint—arthralgia 228 5.26
Incoming mail NOS 191 4.40
Rheumatoid arthritis 182 4.20
Telephone encounter 119 2.74
Had a chat with patient 91 2.10
Erythrocyte sedimentation rate 70 1.61
Nursing care blood sample taken 56 1.29
Blood withdrawal 53 1.22
Arthritis 50 1.15
Pain 47 1.08
Seen by rheumatologist 47 1.08
Seen in hospital outpatients 44 1.01
Incoming mail 43 0.99
Hand pain 42 0.97
Knee pain 41 0.95
Communication from: 40 0.92
Foot pain 38 0.88
Figure 1 Timing of earliest DMARD text string or code.
DMARD, disease-modifying antirheumatic drug; RA,
rheumatoid arthritis.
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this study. In 10% of patients, this was over 4 weeks
before the diagnosis date. The process of ovarian cancer
diagnosis is similar to RA as the GP will refer the patient
to specialists for diagnosis on suspicion of the condition,
and the diagnosis will come back to the GP in a letter.
Free text has, however, been established as valuable in
increasing the sensitivity of case-ascertainment strategies
in EHR research33 and particularly in RA.21 Free text is
already being employed in many studies using US
hospital-based electronic records, and in some UK
research groups, but extraction of free text information
from UK general practice patient records is rare. Privacy
and governance issues can be of concern, as free text is
harder to strip of patient identiﬁers than structured
data; however, the science of automated deidentiﬁcation
of text is now well established.34 Once text is anonymised,
natural language processing algorithms can extract infor-
mation from medical text at scale.
It could be speculated that within CPRD data, where
there are delayed codes, there may also be codes that
are completely missing. The results of this study do not
give us any information about how many patients might
never receive a diagnostic code for their RA, and fur-
thermore, very few validation studies of CPRD data have
assessed rates of false negatives or the sensitivity of case-
ascertainment strategies. The Thomas et al16 study
showed that codes for RA had high validity or PPV, but
no attempt was made to assess sensitivity. Many EHR
studies have explicitly ‘increased the probability of
including only well-deﬁned and pure cases’,35 that is,
maximising speciﬁcity over sensitivity, which may be pref-
erable in studies examining relative risks. However, this
strategy may not be appropriate for estimating inci-
dence, prevalence or healthcare audit studies where
ﬁnding every case of disease is imperative. Developing
and implementing methods for assessing sensitivity of
case ascertainment in general practice record databases
would lead to substantial improvements in our under-
standing of data quality and it is likely that use of free
text will be a key part of such methods.
Implications for clinical care
Patients with RA need active management for their
condition, and getting the right care early in the disease
process is critical. In general practice, this means prescrib-
ing the appropriate treatment for RA, assessing relevant
comorbidities and their treatment, and taking care of the
patient’s general health and well-being. With the increase
in shared care between different clinicians within the
general practice, having diagnoses accurately coded is
important. Since 2013, GPs in the UK have been ﬁnan-
cially incentivised to keep a register of their patients with
RA to ensure care is given according to guidelines as part
of the Quality and Outcomes Framework (QOF).36 The
ﬁndings in this study suggest that during the study period
(2005–2008), letters from specialists containing diagnostic
information were either sometimes delayed in reaching
the GP, or content of letters was not properly coded when
received. However, since data collection in 2005–2008,
there have been changes in service delivery and organisa-
tion, a change from paper based to electronic transfer of
information between primary and secondary care, and the
introduction of NICE and QOF guidance for RA. It is
likely that coding quality has improved in recent years, so
that examples of low-quality coding are over-represented
in our sample and do not reﬂect current practice. Free
text ﬁelds may not add as much information in 2016 as
they did in 2008, but further study of more recent data is
needed to explore this.
Another possible explanation for the apparent delay
in coding is that there may be a genuine delay in estab-
lishing a deﬁnitive diagnosis, because RA is a heteroge-
neous disease. DMARDs may be initiated for a working
diagnosis of inﬂammatory arthritis or other related
inﬂammatory conditions. However, we found no evi-
dence for more diagnoses of these inﬂammatory condi-
tions in the records of the patients with probable delay,
although there was more information in text regarding
inﬂammatory arthritis. This adds further to the case that
for conditions where diagnosis is a process that unfolds
over time, much diagnostic information is found in the
free text rather than the codes.
Strengths and limitations of the study
A strength of this study was that the annotation was per-
formed to high standard, in triplicate by domain experts,
with adjudication by a senior clinician. This study used a
sample of 294 patients, and produced a 218 000 word
gold standard text corpus. This corpus could be used in
the development of natural language processing algo-
rithms which may be generalisable to other studies of RA
in UK general practice patient record data.
A further strength is the data source, CPRD, which is
believed to be representative of the UK population.
However, despite random sampling, the small sample
may not represent all patients with RA, or indeed all
coding practices in the UK. The data also cannot inform
us about other countries’ primary care systems and
recording of RA. Other European countries such as the
Netherlands also extract and use data from primary care
providers for research, but these systems use ICPC codes
rather than Read codes. An investigation of delay in
recording of cases of disease in these databases by using
free text might also be proﬁtable.
One further limitation is that negation and modiﬁers
were not marked within the text, and the inﬂuence of
these linguistic features on the results is unknown. Future
work should assess the impact of modiﬁers and negation.
However, if their impact is minimal, then keyword
searches, which are quick and easy to specify, may be
adequate to extract appropriate information from text.
CONCLUSIONS
Electronic medical records have a key purpose in patient
management and care, and are also now a key resource for
research. Their primary purpose remains as a clinical
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record, but the secondary purpose of research can be suc-
cessfully achieved with careful understanding of how diag-
noses are recorded. This study shows that RA is coded as a
diagnosis at variable intervals from the ﬁrst indication of
the disease. Late diagnostic coding has implications for
the provision of routine care, especially for those with
comorbidities and with ongoing high-risk medications.
Text ﬁelds are an integral part of EHRs and researchers
using EHR data should adapt their practice to take account
of this additional and clinically important information, for
example, by incorporating text into case-ascertainment
strategies. Natural language processing techniques have the
potential to extract information from text at scale.
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